Ozempic
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Ozempic in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Ozempic.
3
Global Revenue Ranking
4
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Ozempic
The company’s semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid
The progressive condition affects approximately 40% of type 2 diabetes patients
The experimental dose is also being evaluated in adults with obesity and type 2 diabetes
The company expects to file for regulatory approvals of the drug in this indication next year
The weight management drug was found to significantly reduce the risk of major adverse cardiovascular events
Approximately 7.6 million people are living with heart and circulatory diseases in the UK
Researchers from the University of Oxford analysed records from more than 100 million patients in the US
GLP-1 treatment reduced the risk of gallbladder cancer by 65% and meningioma by 63%
Approximately 40% of people living with type 2 diabetes will develop CKD
PME spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
An estimated 40% of people living with type 1 or type 2 diabetes will develop CKD in their lifetime
You know, what with it being the end of the year and all that
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology